Latest Breaking News On - அலெக்ஸ் ஸ்டீவன்சன் - Page 7 : comparemela.com
Longevity Acquisition Corporation Announces 4D pharma Joining Landmark Parkinson s Progression Markers Initiative
News provided by
Share this article
Share this article
NEW YORK, Dec. 21, 2020 /PRNewswire/ Longevity Acquisition Corporation (NASDAQ: LOAC) (the Company ), a publicly-traded special purpose acquisition company, announced today that on December 18, 2020, 4D pharma plc (AIM: DDDD) ( 4D pharma ), a pharmaceutical company leading the development of Live Biotherapeutic products ( LBPs ) - a novel class of drug derived from the microbiome, and a business combination target of LOAC, has joined the Parkinson s Progression Markers Initiative ( PPMI ) as an industry partner. PPMI is a landmark study sponsored by The Michael J. Fox Foundation to better understand Parkinson s disease and accelerate the development of new treatments.
Yongda
Jiangsu
China
United-states
Shanghai
Karen-smith
Alex-stevenson
Matthew-chen
Sohini-chowdhury
Purpose-acquisition-company
Whale-management-corporation
Exchange-commission-on